The original PROOF-HD trial of pridopidine was negative, but a new analysis showed it has clinically meaningful effects in ...

"Patients with Huntington's disease are known to have imbalances ... MD of 0.10 points Symbol digit modalities test: MD of 0.33 points Post hoc analyses did not show significant beneficial effects ...

Sage Therapeutics’ SAGE phase II study evaluating its neuropsychiatric candidate, dalzanemdor (SAGE-718), for treating cognitive impairment (CI) associated with Huntington’s Disease (HD ...

Parkinson’s and Huntington’s disease, atherosclerosis, Alzheimer’s disease, and obesity. ZyVersa Therapeutics, Inc. was founded in 2014 and is based in Weston, Florida.

The company’s products include INGREZZA for tardive dyskinesia and chorea associated with Huntington’s disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital ...

Huntington’s Disease, and stroke-related motion challenges. The device harnesses the power of technology to assist those who have difficulty raising their arms due to limited mobility issues ...

or search for huntington's disease to find more great stock images and vector art. Vector dementia symbol in outline style. Editable illustration Vector dementia icon in outline style. Medical ...

The number of people who have the gene that causes Huntington's disease in Northern Scotland has been accurately counted for ...

Northern Scotland has one of the highest rates of Huntington’s disease globally, according to new research from the ...

uniQure's AMT-130 receives Breakthrough Therapy designation from FDA for Huntington's disease, based on promising clinical trial data. uniQure N.V. announced that the U.S. FDA has granted ...

AMT-130 is administered through magnetic resonance imaging-guided, convection-enhanced stereotactic neurosurgical delivery into the striatum.